Nasdaq · Technology
MESA LABORATORIES INC /CO/ (MLAB)
As-reported financials and recent SEC filings for MESA LABORATORIES INC /CO/, latest fiscal period FY2026. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$249.1M
Net income
$6.7M
Net margin
2.7%
Diluted EPS
$1.21
ROE
3.6%
P/E (TTM)
84.6×
Market cap
$565.9M
Debt / equity
0.4×
Income statement (as reported)
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $249.1M | $241.0M | $216.2M | $219.1M | $184.3M |
| Gross profit | $158.3M | $150.9M | $133.3M | $133.7M | $109.1M |
| Operating income | $18.5M | $16.3M | $-272.1M | $3.3M | $4.7M |
| Net income | $6.7M | $-2.0M | $-254.2M | $930,000 | $1.9M |
| Diluted EPS | $1.21 | $-0.36 | $-47.20 | $0.17 | $0.35 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-23
View on EDGAR →42026-06-23
View on EDGAR →42026-06-23
View on EDGAR →1442026-06-22
View on EDGAR →1442026-06-22
View on EDGAR →42026-06-17
View on EDGAR →42026-06-17
View on EDGAR →42026-06-17
View on EDGAR →Go deeper on MLAB
Search MESA LABORATORIES INC /CO/’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.